Clinical trial

Study of Sildenafil Citrate During and After Radiotherapy/Hormone Therapy for Erectile Function Versus Radiotherapy/Hormone Therapy for Prostate Cancer

NCT00142506

Drugs and interventions used in this trial

2 registered

These interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.

Search this trial's interventions

DRUG · Unmapped registry intervention sildenafil citrate and questionaires Find medicine records · Find other trials using this name

DRUG · Unmapped registry intervention placebo tablets and questionaires Find medicine records · Find other trials using this name

Study at a glance

Registry-backed

Study of Sildenafil Citrate During and After Radiotherapy/Hormone Therapy for Erectile Function Versus Radiotherapy/Hormone Therapy for Prostate Cancer

Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE3

Read study objectives, eligibility and outcome measures at ClinicalTrials.gov

StatusCOMPLETED

Study typeINTERVENTIONAL

Start date2005-02-01

PhasePHASE3

Conditions

Prostate Cancerverified · MONDO: prostate cancer

Erectile Dysfunctionverified · MONDO: erectile dysfunction

Interventions

sildenafil citrate and questionairesDRUG

placebo tablets and questionairesDRUG

Sponsors & collaborators

Memorial Sloan Kettering Cancer Centerlead sponsor

Icahn School of Medicine at Mount Sinaicollaborator

Beth Israel Medical Centercollaborator

St. Luke's-Roosevelt Hospital Centercollaborator

Mapped research locations

New YorkNew York, United States1 CommackNew York, United States1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT00142506 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.